Recently, Gössi et al. reported that patients who received two doses of COVID-19 vaccine after CAR T-cell therapy had very low seropositivity (23%), with an improvement in antibody titers and anti-spike protein IgG after a third and fourth booster [32]. This evidence concerns the gene CHMP5 and COVID-19.